DOI: 10.1055/s-00034915

Onkologische Welt

References

Ascierto PA. et al
Prognostic impact of baseline tumuor immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib..

Ann Oncol 2020;
31: 153-159 doi:10.1016/j.annonc.2019.10.002

Download Bibliographical Data

Access:
Access: